Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDQuarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2025 | 4 | $0.88 | $0.94 | $0.91 |
Q2 2025 | 2 | $0.88 | $0.94 | $0.91 |
Q3 2025 | 2 | $0.89 | $0.95 | $0.92 |
Q4 2025 | 2 | $1.02 | $1.10 | $1.06 |
Q1 2026 | 1 | $0.97 | $1.05 | $1.01 |
Q2 2026 | 1 | $0.98 | $1.06 | $1.02 |
Q3 2026 | 1 | $0.94 | $1.01 | $0.97 |
Q4 2026 | 1 | $0.94 | $1.01 | $0.97 |
Organon & Co. last posted its earnings results on Thursday, February 13th, 2025. The company reported $0.9 earnings per share for the quarter, missing analysts' consensus estimates of $0.92 by $0.02. The company had revenue of 1.59 B for the quarter and had revenue of 6.40 B for the year. Organon & Co. has generated $3 earnings per share over the last year ($3.33 diluted earnings per share) and currently has a price-to-earnings ratio of 4.47. Organon & Co. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 13th, 2025 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
02/28/2025 | Q4 2024 | N/A | $0.42 | N/A | $1.59 B | $1.59 B |
11/01/2024 | Q3 2024 | N/A | $1.39 | N/A | $1.56 B | $1.58 B |
08/07/2024 | Q2 2024 | N/A | $0.76 | N/A | $1.61 B | $1.61 B |
05/03/2024 | Q1 2024 | N/A | $0.79 | N/A | N/A | $1.62 B |
02/26/2024 | Q4 2023 | N/A | $2.14 | N/A | $1.55 B | $1.60 B |
11/03/2023 | Q3 2023 | N/A | $0.23 | N/A | $1.57 B | $1.52 B |
08/09/2023 | Q2 2023 | N/A | $0.95 | N/A | $1.57 B | $1.61 B |
05/04/2023 | Q1 2023 | N/A | $0.70 | N/A | N/A | $1.54 B |
02/27/2023 | Q4 2022 | N/A | $0.42 | N/A | N/A | $1.49 B |
11/03/2022 | Q3 2022 | N/A | $0.89 | N/A | $1.51 B | $1.54 B |
08/04/2022 | Q2 2022 | N/A | $0.92 | N/A | $1.53 B | $1.59 B |
05/05/2022 | Q1 2022 | N/A | $1.37 | N/A | N/A | $1.57 B |
03/21/2022 | Q4 2021 | N/A | $0.80 | N/A | N/A | $1.60 B |
11/12/2021 | Q3 2021 | N/A | $1.27 | N/A | $1.58 B | $1.60 B |
08/16/2021 | Q2 2021 | N/A | $1.68 | N/A | $1.52 B | $1.60 B |
06/21/2021 | Q1 2021 | $1.52 | $1.58 | 0.06 | N/A | $1.51 B |
12/30/2020 | Q4 2020 | N/A | $1.45 | N/A | N/A | $3.18 B |
09/29/2020 | Q3 2020 | N/A | $2.16 | N/A | N/A | $1.61 B |
06/29/2020 | Q2 2020 | N/A | $2.14 | N/A | N/A | $1.53 B |
03/30/2020 | Q1 2020 | N/A | $2.78 | N/A | N/A | $1.78 B |
Organon & Co. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 13th, 2025 based offlast year's report dates.
The conference call for Organon & Co.'s latest earnings report can be listened to online.
The conference call transcript for Organon & Co.'s latest earnings report can be read online.
Organon & Co. (:OGN) has a recorded annual revenue of $6.40 B.
Organon & Co. (:OGN) has a recorded net income of $864.00 M.Organon & Co. has generated $3.36 earnings per share over the last four quarters.
Organon & Co. (:OGN) has a price-to-earnings ratio of 4.47 and price/earnings-to-growth ratio is -0.13.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED